Pfizer up 17% in US as Nexium 24HR advances

30 April 2015 - Deborah Wilkes

Archived

Pfizer Consumer Healthcare's US sales rose by 17% in the first quarter of 2015 following the launch of Nexium 24HR a year ago. Chief executive officer Ian Read said the business "is strategically important" to Pfizer.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: